No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Administration, Intravesical
-
Angiogenesis Inhibitors / analysis
-
Apoptosis / drug effects
-
Apoptosis / immunology
-
BCG Vaccine / administration & dosage
-
BCG Vaccine / therapeutic use
-
Carcinoma in Situ / diagnosis
-
Carcinoma in Situ / immunology
-
Carcinoma in Situ / therapy
-
Carcinoma, Transitional Cell / diagnosis*
-
Carcinoma, Transitional Cell / immunology
-
Carcinoma, Transitional Cell / therapy*
-
Chemotherapy, Adjuvant
-
Cystectomy
-
Endothelial Growth Factors / analysis
-
Genetic Therapy / methods
-
Humans
-
Immunohistochemistry
-
Immunotherapy / methods
-
Lymphokines / analysis
-
Nuclear Proteins*
-
Prognosis
-
Proto-Oncogene Proteins / analysis
-
Proto-Oncogene Proteins c-mdm2
-
Thrombospondin 1 / analysis
-
Tumor Suppressor Protein p53 / analysis*
-
Tumor Suppressor Protein p53 / pharmacology
-
Tumor Suppressor Protein p53 / therapeutic use*
-
Urinary Bladder Neoplasms / diagnosis*
-
Urinary Bladder Neoplasms / immunology
-
Urinary Bladder Neoplasms / therapy*
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
-
rho GTP-Binding Proteins / analysis
Substances
-
Angiogenesis Inhibitors
-
BCG Vaccine
-
Endothelial Growth Factors
-
Lymphokines
-
Nuclear Proteins
-
Proto-Oncogene Proteins
-
Thrombospondin 1
-
Tumor Suppressor Protein p53
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
-
MDM2 protein, human
-
Proto-Oncogene Proteins c-mdm2
-
rho GTP-Binding Proteins